India to Singapore: Nivolumab Export Trade Route

The India to Singapore Nivolumab corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $1.1M USD. The route is dominated by NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $65.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with nivolumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 20.9%, placing it at rank #6 among India's top nivolumab export destinations globally.

On the import side, key buyers of Indian nivolumab in Singapore include ALMAC PHARMACEUTICAL SERVICES PTE LIMITED, BIORELIANCE TESTING SERVICES. ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the single largest importer with 2 shipments valued at $1.1M USD.

India's nivolumab exports to Singapore are driven primarily by a handful of large-scale manufacturers. NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Singapore benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $65.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as nivolumab aex ip,batch no:p45-bm-engg-0001 mfg. date : apr-25 & exp. date : oct-25 and nivolumab pals (pac load),batch no:p45-bm-engg-0001 mfg. date : apr-25 & exp. date : oct-25, suggesting that buyers in Singapore tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ALMAC PHARMACEUTICAL SERVICES PTE LIMITED is the largest importer with 2 shipments worth $1.1M USD — representing 100% of all nivolumab imports from India on this route.